Simonian v. Badalian CA2/1

CourtCalifornia Court of Appeal
DecidedJuly 12, 2024
DocketB323737
StatusUnpublished

This text of Simonian v. Badalian CA2/1 (Simonian v. Badalian CA2/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Simonian v. Badalian CA2/1, (Cal. Ct. App. 2024).

Opinion

Filed 7/12/24 Simonian v. Badalian CA2/1 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION ONE

THEOD SIMONIAN et al., B323737

Plaintiffs and Appellants, (Los Angeles County Super. Ct. No. 20STCV00400) v.

VAHE BADALIAN,

Defendant and Respondent.

APPEAL from a judgment of the Superior Court of Los Angeles County, William A. Crowfoot, Judge. Reversed. Shegerian & Associates, Carney R. Shegerian, Anthony Nguyen, Mark Lim, Aadil Muhammad and Iman Alamdari for Plaintiffs and Appellants. Cole Pedroza, Kenneth R. Pedroza, Cassidy C. Davenport, Matthew S. Levinson; Packer O’Leary & Corson, Robert B. Packer and Hilliary B. Powell for Defendant and Respondent Vahe Badalian. ___________________________________

In a medical malpractice action arising from the death of a post-operative patient in an ICU, the plaintiffs’ expert in critical care medicine opined that the decedent’s cardiologist fell below the standard of care by failing to order serial hemoglobin monitoring, and had such monitoring been undertaken there would have been enough time to prevent the fatal heart attack he suffered. After finding the expert’s opinion to be inadmissible essentially because the expert failed to list the exact cause of death as his particular area of expertise, the trial court granted summary judgment to the defendant. We reverse because nothing in the record suggests an expert in critical care medicine cannot offer an expert opinion on post-operative hemoglobin monitoring and on the result from the failure to monitor. BACKGROUND Razmi Simon, age 76, who suffered from chronic cardiovascular disease, hypertension and hyperlipidemia, was admitted to Glendale Adventist Medical Center requiring immediate surgery for a fractured hip. Dr. Vahe Badalian, Simon’s cardiologist and primary care provider, examined Simon at his bedside and contacted Michael Abdulian, a surgeon, who performed surgery on Simon’s hip on the morning of November 20, 2018. Simon, who took aspirin and prasugrel as antiplatelet therapy, had a preoperative hemoglobin level of 12.6 grams per deciliter, an amount raising no medical issues. He lost only 50 milliliters of blood during the surgery, not an amount to raise concern of excessive bleeding. In the evening of November 21, 2018, Simon developed tachycardia and complained about pain in his leg and chest. Dr.

2 Badalian ordered a complete blood count test, which revealed that Simon’s hemoglobin had dropped to 6.8 grams per deciliter, reflecting critical perioperative blood loss. An electrocardiogram was ordered, which showed Simon was suffering a heart attack. Simon was taken to the ICU, where he underwent a series of interventions before dying on the morning of November 23, 2018, from “cardiopulmonary arrest, cardiogenic shock, [and] acute coronary insufficiency secondary to supply demand mismatch.” Lidoosh Akoupian, Theod Simonian, and Arbey Simon, Simon’s wife and sons, sued Dr. Badalian for professional negligence, alleging he breached the standard of care by failing to order serial hemoglobin monitoring after Simon’s operation. Plaintiffs alleged that failure to monitor Simon’s hemoglobin levels caused a failure to detect that he was bleeding internally until it was too late to prevent him from suffering a fatal heart attack. Had Simon’s hemoglobin been checked earlier, plaintiffs alleged, his blood loss would have been detected in time to give him a transfusion, which would have prevented his death. Dr. Badalian moved for summary judgment, supported by the declaration of Fernando Roth, M.D., a cardiologist in private practice and attending faculty member with a Clinical Professor appointment at the Keck USC School of Medicine. Dr. Roth opined that the standard of care does not require hemoglobin monitoring following orthopedic surgery unless the patient demonstrates signs or symptoms of bleeding, such as hypotension, tachycardia, increased respirations, or frank bleeding. Roth declared that Dr. Badalian appropriately monitored Simon throughout his admission, because his post- operative vitals and clinical presentation were normal and not

3 suggestive of bleeding, and thus there was no indication of the need to measure his hemoglobin levels prior to his complaints. Roth also declared that no deviation from the standard of care caused or contributed to Simon’s death because even if post- operative hemoglobin monitoring had been ordered, the results would not have predicted Simon’s sudden myocardial infarction and other associated symptoms. This is so, Roth declared, because there likely would have been no drop in Simon’s hemoglobin values which would have prompted intervention, because the infarction was a sudden, acute event caused by a ruptured ulcer or breach of a vessel. Had Simon been experiencing postoperative bleeding for an extended time, Roth declared, he would have exhibited signs or symptoms of such bleeding, such as tachycardia and hypotension, which did not occur. Plaintiffs opposed the motion, offering the declaration of Kevin Shaw, M.D., an internist, pulmonologist, and critical care specialist currently serving as the Medical Director of the intensive care unit at Scripps Memorial Hospital in Encinitas. Dr. Shaw declared he “routinely cared for patients with advanced pulmonary diseases, heart transplantation, cardiogenic shock, extracorporeal membranous oxygenation, immunosuppression, massive trauma, septic shock, and the like,” and currently worked 15 to 20 shifts per month caring for critically ill patients with a variety of pathologies. Dr. Shaw declared, “The standard of care in [Simon’s] situation would have been serial hemoglobin monitoring in the postoperative setting, with transfusion and potential CT imaging of the thigh with any significant drop in hemoglobin, or pain out of proportion to what would be expected. In the event that the

4 patient’s hemoglobin was to drop, immediate transfusion of blood products, with consideration of platelet product transfusion, or potentially an angiographic intervention, would be able to minimize cardiovascular consequences and could have avoided Mr. Simon death.” “Hemorrhagic complications from femur surgery are not uncommon,” Dr. Shaw declared, and “can be difficult to detect immediately because the thigh tends to be large, with deep pockets of potential space between muscle and fatty tissue, able to contain a large amount of blood volume before it is clinically apparent with signs such as bruising. As a cardiologist, and as the very prescriber of Mr. Simon’s aspirin and prasugrel therapy, Dr. Badalian should have been intimately familiar with the mechanism of action of these medications. Dr. Badalian was clearly aware of the risks of Mr. Simon’s dual antiplatelet therapy, as evidenced by his note regarding his prasugrel use.” Dr. Shaw declared that Dr. Badalian fell below the standard of care, by “fail[ing] to appropriately monitor the laboratory values of Mr. Simon. Specifically, [he] failed to follow the patient’s hemoglobin values for evidence of perioperative blood loss. Mr. Simon was anticoagulated with dual antiplatelet therapy, including aspirin and prasugrel. Prasugrel is well- known to cause significant hemorrhagic complications in the setting of the surgical procedures. Because of this, it is typically held for 7 days prior to elective surgery. In the setting of emergent surgery, such as the surgery of Mr. Simon, precautions must be taken to ensure minimal risk of hemorrhagic complications.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sargon Enterprises, Inc. v. University of Southern California
288 P.3d 1237 (California Supreme Court, 2012)
Sinz v. Owens
205 P.2d 3 (California Supreme Court, 1949)
Huffman v. Lindquist
234 P.2d 34 (California Supreme Court, 1951)
Mitchell v. Gonzales
819 P.2d 872 (California Supreme Court, 1991)
Dumas v. Cooney
235 Cal. App. 3d 1593 (California Court of Appeal, 1991)
Johnson v. Superior Court
49 Cal. Rptr. 3d 52 (California Court of Appeal, 2006)
Kelley v. Trunk
78 Cal. Rptr. 2d 122 (California Court of Appeal, 1998)
Powell v. Kleinman
59 Cal. Rptr. 3d 618 (California Court of Appeal, 2007)
Alexander v. Codemasters Group Limited
127 Cal. Rptr. 2d 145 (California Court of Appeal, 2002)
Spitzer v. the Good Guys, Inc.
96 Cal. Rptr. 2d 236 (California Court of Appeal, 2000)
Osborn v. Irwin Memorial Blood Bank
5 Cal. App. 4th 234 (California Court of Appeal, 1992)
Avivi v. Centro Medico Urgente Medical Center
71 Cal. Rptr. 3d 707 (California Court of Appeal, 2008)
Aguilar v. Atlantic Richfield Co.
24 P.3d 493 (California Supreme Court, 2001)
Neiman v. Leo A. Daly Co.
210 Cal. App. 4th 962 (California Court of Appeal, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Simonian v. Badalian CA2/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/simonian-v-badalian-ca21-calctapp-2024.